Editas Medicine EDIT
NASDAQ EDIT
$2.49 -0.02 (-0.80%)
At close: Oct 22, 2026 · 4:00 PM EDT

Editas Medicine (EDIT) Times Interest Earned (2025)

Updated

Editas Medicine's (EDIT) Times Interest Earned was -10.23 for Q3 2025.

Analysis

Editas Medicine (EDIT) Times Interest Earned (2025) Analysis & Trends

Over the twelve months ended Sep 30, 2025, Editas Medicine's Times Interest Earned came in at -29.97.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 28.50
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 10.28
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 7.27
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 5.22
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -42.08
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Editas Medicine 222.97 Mn -488.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -10.23
Jun 30, 2025 -25.52
Mar 31, 2025 -34.37
API Access

Editas Medicine Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=EDIT&period=max&api_key=YOUR_API_KEY